Argatroban Injection
Product Images NDC 65219-429
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Argatroban (NDC 65219-429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Arg07 0000 02)
Figure 2 (Arg07 0000 03)
Figure 3 (Arg07 0000 04)
Figure 4 (Arg07 0000 05)
Fresenius Kabi Logo (Arg07 0000 06)
Principal Display Panel – 50 mg/50 mL – Vial Label (Arg07 0000 07)
This is a description of a medication called "Argatroban Injection." It is a 50mL single-dose vial that should not be diluted before administration and is for intravenous infusion only. It contains 1mg of Niflumic acid, 2mg of Protein hydrochloride, 3.04mg of Dehydrated Alcohol, and 9mg of Sodium Chloride in water for injection. There are no preservatives included. The usual adult dosage should be found on the package. The drug should be stored at a temperature of 20°C to 25°C (68°F to 77°F) and not frozen. The remaining text is not available.*
Principal Display Panel – 50 mg/50 mL – Carton (Arg07 0000 08)
This document provides information about a product containing Argatroban. The product comes in a 50 mL Single-Dose Vial and must be stored in a controlled room temperature environment. The usual adult dosage is not mentioned. Users are cautioned not to dilute before the administration of the product. Details about printing 2D code, Sr. No, GTIN, lot number, and exp date during online packing are also included.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.